Frontiers

UPFRONT Winter 2014

​ A Summer of Progress A beautiful autumn followed a summer of successes at the OSUCCC – James. MICHAEL A. CALIGIURI, MD DIRECTOR, COMPREHENSIVE CANCER CENTER CHIEF EXECUTIVE OFFICER, JAMES CANCER HOSPITAL AND SOLOVE RE ...[Read more]
Published: Jan-16-14 | 75  Comments | 0  Link to this post

FRONTLINE Winter 2014

​ The Supreme Court Gene-Patenting Decision Has Far-Reaching Consequences By REBECCA NAGY, MS, CGC, clinical associate professor of Human Genetics and president of the National Society of Genetic CounselorsOn June 13, 2013, the United ...[Read more]
Published: Jan-16-14 | 12  Comments | 0  Link to this post

BREAKTHROUGH Winter 2014

CLINICAL IMPLICATIONS New Aent Shows Promise in CLL and MCL JOHN C. BYRD, MD, professor and director of the Division of Hematology, and a CLL specialist at the OSUCCC – James KRISTIE BLUM, MD, associate professor i ...[Read more]
Published: Jan-16-14 | 1  Comment | 0  Link to this post

Of Note Winter 2014

​ GRANTS DENIS GUTTRIDGE, PhD, professor of Medicine and member of the OSUCCC – James Molecular Biology and Cancer Genetics Program, has received a four-year, $1.4 million grant (CA180057) from the Nation ...[Read more]
Published: Jan-16-14 | 12  Comments | 0  Link to this post

A Wound That Never Heals Winter 2014

​ ​ A WOUND THAT NEVER HEALS Research is revealing the intimate links between inflammation and malignancy; the work has important implications for cancer treatment and prevention BY DARRELL E. WARD A cut on the finger ...[Read more]
Published: Jan-16-14 | 8  Comments | 0  Link to this post

A Personal Vision Winter 2014

​ ​ A Personal Vision The new director of Neuro-Oncology favors team research and new clinical-trial designs to develop novel drugs for brain tumors By BOB HECKER Vinay Puduvalli’s career trek from medical school in his ...[Read more]
Published: Jan-16-14 | 3  Comments | 0  Link to this post

Thyroid Cancer Winter 2014

​ SEEKING ANSWERS FOR THYROID CANCER Renewed NCI funding supports bedside-to-bench research driven by the needs of patients BY BOB HECKER Thyroid cancer incidence in the United States is rising at the fastest rate of a ...[Read more]
Published: Jan-16-14 | 2  Comments | 0  Link to this post

Bench to Bedside winter 2014

​OSU-12055: Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection (SAFE-MILND) HYPOTHESIS: That minimally invasive groin dissection is a safe procedure; 2. That the learning curve for minimally invasive inguinal lymph no ...[Read more]
Published: Jan-16-14 | 2  Comments | 0  Link to this post

 Next >>